We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.11B
AUM Growth
+$52.8M
Cap. Flow
-$12.7M
Cap. Flow %
-1.14%
Top 10 Hldgs %
19.77%
Holding
2,152
New
581
Increased
526
Reduced
430
Closed
561

Sector Composition

Rank Sector Weight
1 Technology 16.1%
2 Healthcare 13.61%
3 Communication Services 11.16%
4 Consumer Discretionary 6.46%
5 Real Estate 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVIX
51
DELISTED
VelocityShares Daily 2x VIX Short Term ETN
TVIX
$4.09M 0.37%
+3,608
New +$6.06M
EMB icon
52
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$3.95M 0.36%
+33,900
New +$3.92M
NVDA icon
53
NVIDIA
NVDA
$4.86T
$3.85M 0.35%
862,560
+303,360
+54% +$1.26M
SRPT icon
54
Sarepta Therapeutics
SRPT
$1.57B
$3.82M 0.34%
84,226
-3,827
-4% -$153K
DDC
55
DELISTED
Dominion Diamond Corporation
DDC
$3.82M 0.34%
269,305
+262,899
+4,104% +$3.66M
HYG icon
56
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$3.77M 0.34%
42,431
-68,744
-62% -$6.07M
JNK icon
57
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.07B
$3.65M 0.33%
+32,600
New +$3.63M
TRCO
58
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$3.65M 0.33%
89,269
+22,334
+33% +$908K
PTCT icon
59
PTC Therapeutics
PTCT
$5.64B
$3.63M 0.33%
181,379
-100,845
-36% -$1.97M
EQR icon
60
Equity Residential
EQR
$24.9B
$3.61M 0.33%
54,714
-6,609
-11% -$442K
VWR
61
DELISTED
VWR Corporation
VWR
$3.6M 0.32%
108,688
-205,642
-65% -$6.79M
NDRM
62
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$3.56M 0.32%
91,533
+90,657
+10,349% +$3.33M
BXP icon
63
Boston Properties
BXP
$11.2B
$3.5M 0.32%
28,512
+13,417
+89% +$1.62M
SPLK
64
DELISTED
Splunk Inc
SPLK
$3.5M 0.32%
+52,713
New +$3.3M
EWY icon
65
PUT
iShares MSCI South Korea ETF
EWY
$21.9B
$3.45M 0.31%
+50,000
New +$3.44M
BOBE
66
DELISTED
Bob Evans Farms, Inc.
BOBE
$3.42M 0.31%
+44,139
New +$3.05M
INSM icon
67
Insmed
INSM
$21.4B
$3.4M 0.31%
+108,800
New +$2.07M
CHTR icon
68
Charter Communications
CHTR
$17.3B
$3.34M 0.3%
9,192
+5,865
+176% +$2.18M
UNH icon
69
UnitedHealth
UNH
$376B
$3.34M 0.3%
17,031
-900
-5% -$174K
DELL icon
70
Dell
DELL
$262B
$3.23M 0.29%
148,954
+20,104
+16% +$387K
EA icon
71
Electronic Arts
EA
$53B
$3.19M 0.29%
27,045
+2,287
+9% +$265K
OKSB
72
DELISTED
Southwest Bancorp Inc/OK
OKSB
$3.1M 0.28%
112,682
+19,562
+21% +$502K
KIM icon
73
Kimco Realty
KIM
$17.2B
$3.02M 0.27%
154,467
-45,069
-23% -$884K
VRTX icon
74
Vertex Pharmaceuticals
VRTX
$121B
$3M 0.27%
19,755
+4,461
+29% +$671K
CAVM
75
DELISTED
Cavium, Inc.
CAVM
$2.97M 0.27%
45,000
+15,436
+52% +$977K

Similar funds

Prelude Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Prelude Capital Management held 2,152 positions worth $1.11B, up 5% from $1.06B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Prelude Capital Management's Q3 2017 filing shows 581 new, 526 increased, 430 reduced and 561 closed positions. Its largest new stake was Rockwell Collins: 63,879 shares worth $8.35M. The largest sale was Mobileye N.V., an estimated $25.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Communication Services.

  • Prelude Capital Management's largest Q3 2017 buy was Rockwell Collins: 63,879 shares worth $8.35M.
  • Prelude Capital Management added most to Calpine Corporation in Q3 2017, an estimated $12.6M increase.
  • Prelude Capital Management's biggest Q3 2017 reduction was Gray Television, cutting an estimated $14.3M.
  • Prelude Capital Management fully exited Mobileye N.V. in Q3 2017, selling an estimated $25.8M.
  • Prelude Capital Management's ten largest holdings make up 20% of its $1.11B portfolio in Q3 2017.
  • Prelude Capital Management opened 581 new positions and closed 561 in Q3 2017.
  • Prelude Capital Management's portfolio value rose 5% quarter-over-quarter to $1.11B.

Based on Prelude Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.